Eisai's slow push toward blockbuster Leqembi sales gains steam with $900M forecast

15th May 2026 Uncategorised 0

The company doubled sales of its Biogen-partnered Alzheimer’s disease treatment during its 2025 fiscal year.

More: Eisai's slow push toward blockbuster Leqembi sales gains steam with 0M forecast
Source: fierce